News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
100,854 Results
Type
Article (7333)
Company Profile (36)
Press Release (93481)
Multimedia
Podcasts (25)
Webinars (4)
Section
Business (27898)
Career Advice (129)
Deals (4034)
Drug Delivery (48)
Drug Development (14287)
Employer Resources (12)
FDA (3102)
Job Trends (2139)
News (49815)
Policy (6113)
Tag
2027 Biotech Bay Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (453)
Accelerated approval (25)
ADA (4)
Adcomms (11)
Allergies (66)
Alliances (9051)
ALS (54)
Alzheimer's disease (395)
Antibody-drug conjugate (ADC) (200)
Approvals (3074)
Artificial intelligence (216)
ASCO (68)
Autoimmune disease (141)
Automation (18)
Bankruptcy (20)
Best Places to Work (1795)
BIO (18)
BIOSECURE Act (17)
Biosimilars (187)
Biotechnology (26)
Bladder cancer (60)
Brain cancer (20)
Breast cancer (172)
Cancer (1384)
Cardiovascular disease (69)
Career advice (119)
Career pathing (7)
CAR-T (64)
CDC (13)
Cell therapy (232)
Cervical cancer (14)
Clinical research (12932)
Collaboration (639)
Company closure (3)
Compensation (125)
Complete response letters (48)
COVID-19 (611)
CRISPR (17)
C-suite (255)
Cystic fibrosis (18)
Data (2084)
Denatured (6)
Depression (20)
Dermatology (38)
Diabetes (105)
Diagnostics (663)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (142)
Drug pricing (42)
Drug shortages (1)
Duchenne muscular dystrophy (100)
Earnings (10607)
Editorial (24)
Employer branding (3)
Employer resources (11)
Events (13324)
Executive appointments (203)
FDA (4170)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (11)
Funding (391)
Gene editing (58)
Generative AI (30)
Gene therapy (232)
GLP-1 (178)
Government (1441)
Grass and pollen (1)
Guidances (89)
Healthcare (1981)
Hematology (51)
HIV (19)
Huntington's disease (20)
IgA nephropathy (29)
Immunology and inflammation (113)
Immuno-oncology (46)
Indications (51)
Infectious disease (713)
Inflammatory bowel disease (90)
Inflation Reduction Act (7)
Influenza (43)
Intellectual property (52)
Interviews (11)
IPO (1855)
IRA (16)
Job creations (390)
Job search strategy (108)
JPM (9)
Kidney cancer (6)
Labor market (8)
Layoffs (73)
Leadership (4)
Legal (565)
Liver cancer (14)
Longevity (21)
Lung cancer (205)
Lymphoma (98)
Machine learning (24)
Management (2)
Manufacturing (453)
Marketing (2)
MASH (37)
Medical device (1202)
Medtech (1231)
Mergers & acquisitions (2396)
Metabolic disorders (251)
mRNA (54)
Multiple sclerosis (57)
NASH (2)
Neurodegenerative disease (116)
Neuropsychiatric disorders (9)
Neuroscience (745)
NextGen: Class of 2026 (699)
Non-profit (366)
Now hiring (18)
Obesity (93)
Opinion (83)
Ovarian cancer (54)
Pain (37)
Pancreatic cancer (53)
Parkinson's disease (81)
Partnered (10)
Patents (105)
Patient recruitment (144)
Peanut (31)
People (8555)
Pharmaceutical (9)
Pharmacy benefit managers (7)
Phase 1 (4243)
Phase 2 (5399)
Phase 3 (4721)
Pipeline (2580)
Policy (141)
Postmarket research (298)
Preclinical (1680)
Press Release (66)
Prostate cancer (56)
Psychedelics (10)
Radiopharmaceuticals (47)
Rare diseases (299)
Real estate (940)
Recruiting (5)
Regulatory (5901)
Reports (12)
Research institute (414)
Resumes & cover letters (11)
Rett syndrome (11)
RNA editing (6)
RSV (18)
Schizophrenia (33)
Series A (79)
Series B (42)
Service/supplier (3)
Sickle cell disease (26)
Special edition (6)
Spinal muscular atrophy (25)
Sponsored (19)
Startups (601)
State (1)
Stomach cancer (5)
Supply chain (26)
Tariffs (21)
The Weekly (19)
Vaccines (358)
Venture capital (18)
Weight loss (46)
Women's health (15)
Date
Today (30)
Last 7 days (134)
Last 30 days (560)
Last 365 days (6504)
2026 (3662)
2025 (6029)
2024 (6517)
2023 (6967)
2022 (9062)
2021 (9481)
2020 (8186)
2019 (5844)
2018 (4512)
2017 (5057)
2016 (4615)
2015 (5269)
2014 (3719)
2013 (2893)
2012 (2985)
2011 (3146)
2010 (2573)
Location
Africa (100)
Alabama (18)
Alaska (1)
Arizona (30)
Arkansas (3)
Asia (8264)
Australia (944)
California (2843)
Canada (586)
China (535)
Colorado (60)
Connecticut (87)
Delaware (126)
Europe (15063)
Florida (399)
Georgia (57)
Hawaii (1)
Idaho (14)
Illinois (131)
India (50)
Indiana (73)
Iowa (11)
Japan (148)
Kansas (8)
Kentucky (16)
Louisiana (4)
Maine (9)
Maryland (532)
Massachusetts (2100)
Michigan (37)
Minnesota (93)
Mississippi (4)
Missouri (27)
Montana (5)
Nebraska (1)
Nevada (20)
New Hampshire (6)
New Jersey (890)
New Mexico (4)
New York (750)
North Carolina (366)
North Dakota (10)
Northern California (1428)
Ohio (81)
Oklahoma (12)
Oregon (6)
Pennsylvania (400)
Puerto Rico (5)
Rhode Island (7)
South America (142)
South Carolina (4)
Southern California (1191)
Tennessee (16)
Texas (443)
United States (9618)
Utah (55)
Virginia (33)
Washington D.C. (8)
Washington State (216)
West Virginia (1)
Wisconsin (19)
100,854 Results for "adma biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ADMA Biologics Addresses Misleading Short-Seller Report
March 25, 2026
·
2 min read
Press Releases
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
·
23 min read
Press Releases
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
April 29, 2026
·
2 min read
Press Releases
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
May 4, 2026
·
6 min read
Press Releases
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
February 18, 2026
·
2 min read
Press Releases
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 26, 2026
·
25 min read
Press Releases
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
January 5, 2026
·
2 min read
Press Releases
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
March 2, 2026
·
5 min read
Press Releases
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
January 12, 2026
·
18 min read
Press Releases
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
October 29, 2025
·
2 min read
1 of 10,086
Next
